Sponsored by: Investment Center

Something new in your business?  Click here to submit your business press release

Chamber Corner | Main Street News | Job Hunt | Classifieds | Calendar | Illinois Lottery 

Pfizer recalls Prevnar pneumococcal vaccine

Send a link to a friend

[February 29, 2012]  NEW YORK (AP) -- Drugmaker Pfizer Inc. is recalling one lot of its blockbuster vaccine against pneumococcal disease, Prevnar 13.

HardwarePfizer says the lot is being recalled from a drug wholesaler because Pfizer found the active ingredient was past its expiration date. The company says none was distributed to health care providers.

Prevnar 13 protects against 13 strains of pneumococcal bacteria, which can cause meningitis, pneumonia and ear infections. Prevnar 13 is an improved version of Prevnar, the top-selling vaccine in history. The two versions had about $4.1 billion in sales last year.

Pfizer says it doesn't think the doses being recalled pose any safety or efficacy concerns.

The lot number is F73652. The New York company couldn't immediately say how many doses are in the lot.

[Associated Press]

Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.




< Recent articles

Back to top


News | Sports | Business | Rural Review | Teaching & Learning | Home and Family | Tourism | Obituaries

Community | Perspectives | Law & Courts | Leisure Time | Spiritual Life | Health & Fitness | Teen Scene
Calendar | Letters to the Editor